Clinical trials
Withdrawn trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
128 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 4 |
| 2009 | 6 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 11 |
| 2014 | 6 |
| 2015 | 9 |
| 2016 | 4 |
| 2017 | 8 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 11 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 128 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maastricht University Medical Center | 10 |
| Maastricht Radiation Oncology | 7 |
| UMC Utrecht | 7 |
| University Medical Center Groningen | 6 |
| Bristol-Myers Squibb | 5 |
| Radboud University Medical Center | 5 |
| Rijnstate Hospital | 5 |
| GlaxoSmithKline | 4 |
| AM-Pharma | 3 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 6 |
| Lung Neoplasms | 5 |
| Atrial Fibrillation | 4 |
| Breast Neoplasms | 4 |
| Heart Failure | 4 |
| Neoplasm Metastasis | 4 |
| Acute Kidney Injury | 3 |
| Myelodysplastic Syndromes | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Prostatic Neoplasms | 3 |
Trials
Showing 51 to 75 of 128. Each trial links to its page on Pharma Observatory.
28 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.